Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XTW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,231
Award facts
- Contract value 100% obligated
- $24,231.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,231.30 for 60 tablets of Jakafi 10 mg on September 19, 2025. The contract carries an ultimate completion date of September 22, 2025 and was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, a $499,999,999 vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support military health facilities worldwide.
The Defense Logistics Agency's Medical Supply Chain function funded this award to support federal healthcare operations. Jakafi (ruxolitinib) is a prescription medication used in the treatment of myelofibrosis and other hematologic conditions. DMS Pharmaceutical Group's positioning as a critical supplier within the federal pharmaceutical supply chain reflects its proven capability to deliver specialized medications and medical consumables to Department of Defense healthcare sites across the nation, leveraging its established relationships and logistics infrastructure to meet urgent pharmaceutical procurement needs.
Quick answers
Who was awarded contract SPE2DX25F6XTW?
SPE2DX25F6XTW was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 19, 2025.
How much is contract SPE2DX25F6XTW worth?
The government has obligated $24,231 on SPE2DX25F6XTW.
Is contract SPE2DX25F6XTW an order under another contract?
Yes. SPE2DX25F6XTW is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XTW competed?
The extent of competition for SPE2DX25F6XTW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award